Min Zhong

This inventor holds 41 USPTO granted patents and 23 published patent applications and 10 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Presidio Pharmaceuticals, Inc., Sarcode Bioscience Inc., Sunesis Pharmaceuticals, Inc.. Active years: 2006-2025.

USPTO Granted Patents = 41 (Patent Applications = 23)

% Patents Active = 78.0

EPO Patents = 10 (Patent Applications = 14)

Average Co-Inventor Count = 3.6

ph-index = 11

Forward Citations = 331(Granted Patents)

Location History:

San Francisco, CA (US) (2013 - 2015)
Foster City, CA (US) (2006 - 2018)
Palo Alto, CA (US) (2013 - 2021)

Company Filing History:

12 out of 12

Presidio Pharmaceuticals, Inc.

patents

10 out of 25

Sarcode Bioscience Inc.

patents

8 out of 63

Sunesis Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2006-2025

Loading Chart...

Areas of Expertise:

Bruton's Tyrosine Kinase

HCV Inhibitors

Cellular Adhesion Modulators

Piperidine Compounds

Fused Ring Inhibitors

Heteroaryl Compounds

Aurora Kinase Inhibitors

Bicyclic Compounds

Tricyclic Compounds

Polymorphic Forms

Cardiac Disease Treatments

Compositions and Methods

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12459919 - Polymorphic forms of (R)-4-(1-((3-(difluoromethyl)-1-methyl-1H-pyrazol-4-yl)sulfonyl)-1- fluoroethyl)-N-(isoxazol-3-yl)piperidine-1-carboxamide (2025-11-04),

2. 12344607 - Substituted 5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine-2,4-diones for treating cardiac diseases (2025-07-01),

3. 11123337 - 4-methylsulfonyl-substituted piperidine urea compounds (2021-09-21),

4. 11034693 - Substituted 5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine-2,4-diones for treating cardiac diseases (2021-06-15),

5. 10758525 - 4-methylsulfonyl-substituted piperidine urea compounds (2020-09-01),

6. 10577374 - Bruton's tyrosine kinase inhibitors (2020-03-03),

7. 10124000 - Modulators of cellular adhesion (2018-11-13),

8. 9925177 - 4-methylsulfonyl-substituted piperidine urea compounds (2018-03-27),

9. 9790229 - Bruton's tyrosine kinase inhibitors (2017-10-17),

10. 9663516 - Bicyclic-pyrimidinedione compounds (2017-05-30),

11. 9309260 - Inhibitors of hepatitis C virus (2016-04-12),

12. 9249146 - Bruton'S tyrosine kinase inhibitors (2016-02-02),

13. 9248126 - Modulators of cellular adhesion (2016-02-02),

14. 9216174 - Modulators of cellular adhesion (2015-12-22),

15. 9150554 - Fused ring inhibitors of hepatitis C (2015-10-06),

Title: Inventor Min Zhong - Revolutionizing Technology in Palo Alto

Introduction: Min Zhong is a visionary inventor based in Palo Alto, California, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Min Zhong holds several patents in the areas of artificial intelligence, machine learning, and robotics, showcasing his commitment to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over two decades, Min Zhong has worked with leading tech companies in Silicon Valley, where he has played a pivotal role in developing cutting-edge technologies that have revolutionized various industries.

Collaborations: Throughout his career, Min Zhong has collaborated with top researchers, engineers, and scientists to bring his innovative ideas to life. His collaborative spirit has led to the creation of transformative technologies that have had a lasting impact on society.

Conclusion: Inventor Min Zhong's relentless pursuit of innovation and his passion for pushing the limits of technology have solidified his position as a trailblazer in the field of invention. His work continues to inspire the next generation of inventors and shape the future of technology.